Expanding the availability of scalp cooling to all patients at risk of chemotherapy-induced alopecia Journal Article
| Authors: | Lagmay-Fuentes, P.; Smith, A.; Krus, S.; Lewis, L.; Latif, A.; Gagliardo, T.; Kohli, M. |
| Article Title: | Expanding the availability of scalp cooling to all patients at risk of chemotherapy-induced alopecia |
| Abstract: | Alopecia is an undesirable side effect of cancer chemotherapy. The mitigation of alopecia is a desirable adjunct treatment for patients with cancer. FDA-cleared scalp cooling (SC) devices have been successfully used to prevent or reduce chemotherapy-induced alopecia (CIA). This paper provides an understanding of the implementation and value of the new Insurance-Based Billing Model used in the USA for SC and its benefits compared with the original self-pay model. This improved compensation change will result in all patients in need, including underserved and disadvantaged populations, receiving equitable healthcare by allowing access to this valuable supportive care technology. © 2024 by the authors. |
| Keywords: | reimbursement; alopecia; scalp cooling; insurance-based billing model; self-pay |
| Journal Title: | Journal of Market Access & Health Policy |
| Volume: | 12 |
| Issue: | 3 |
| ISSN: | 2001-6689 |
| Publisher: | MDPI |
| Date Published: | 2024-09-01 |
| Start Page: | 158 |
| End Page: | 168 |
| Language: | English |
| DOI: | 10.3390/jmahp12030013 |
| PROVIDER: | scopus |
| PMCID: | PMC11270178 |
| PUBMED: | 39072307 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
